AGING: It Looks Like We’ve Made a Big Step in Combating Alzheimer’s. “In mid-July, the FDA approved Leqembi, a series of injections that specifically target the plaques that build up in the brains of Alzheimer’s patients. Those plaques are what cause the memory loss, behavioral changes, and terminal decline.”